Drug/Device Combination Product Receives FDA Approval For COPD – Pharmaceutical Processing


Pharmaceutical Processing

Drug/Device Combination Product Receives FDA Approval For COPD
Pharmaceutical Processing
Magnair, an eFlow closed system nebulizer together with Sunovion's Lonhala, is the first eFlow technology-based product to receive FDA approval to treat chronic obstructive pulmonary disease (COPD). Pari Pharma GmbH, a company focused on the ...
Sunovion's COPD nebuliser approved in USpharmaphorum

all 2 news articles »